13D/13G Filings - Camp4 Therapeutics Corp (CAMP)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2024-10-22
6:49 pm
Purchase
2024-10-15 13G CAMP4 Therapeutics Corporation
CAMP
Northpond Ventures II LP 2,238,244
11.500%
2,238,244increase
(New Position)
Filing
History
2024-10-22
5:50 pm
Purchase
2024-10-15 13D CAMP4 Therapeutics Corporation
CAMP
Polaris Management Co. VII L.L.C. 2,625,062
13.500%
2,625,062increase
(New Position)
Filing
History
2024-10-22
4:19 pm
Purchase
2024-10-15 13G CAMP4 Therapeutics Corporation
CAMP
AH Bio Fund I L.P. 2,125,339
10.900%
2,125,339increase
(New Position)
Filing
History
2024-10-22
4:17 pm
Purchase
2024-10-15 13D CAMP4 Therapeutics Corporation
CAMP
5AM Ventures VI L.P. 2,927,915
15.000%
2,927,915increase
(New Position)
Filing
History
2024-10-22
4:16 pm
Purchase
2024-10-15 13D CAMP4 Therapeutics Corporation
CAMP
Enavate Sciences GP, LLC 3,785,802
19.400%
3,785,802increase
(New Position)
Filing
History